Related by context. All words. (Click for frequent words.) 72 dialed Ybarra 71 Islet cell 68 undergoing hematopoietic stem 68 Allogeneic stem cell 67 haematopoietic stem cell 66 autologous hematopoietic stem cell 65 Cojocaru correspondent 65 allogeneic hematopoietic cell 65 allogeneic hematopoietic stem cell 65 Hematopoietic stem cell 64 mismatched bone marrow 64 allogenic stem cell 63 pretransplant 63 matching marrow donor 62 Umbilical cord stem cells 62 allogeneic bone marrow 62 hematopoietic cell 62 transplantation HCT 61 allogeneic stem cell 61 refractory colorectal cancer 61 kidney liver pancreas 61 autoimmune disorders asthma 60 pancreatic islet cell 60 immunosuppression therapy 60 hematological parameters 60 fusion enhancers 60 Regenerative Cell 60 Transplant Rejection 60 organ perfusion 60 immunologically compatible 60 drug belatacept 59 infarcted myocardium 59 unresectable tumors 59 Islet transplantation 59 immunosuppressive regimen 59 allogenic 59 lymphoid organs 58 kidney urologic 58 secretes insulin 58 relapsed MM 58 oral picoplatin 58 psoriasis Crohn disease 58 recombinant erythropoietin 58 antirejection 58 stem cell engraftment 58 adjuvant cisplatin 58 Cloning embryos 58 nonvascular 58 pancreatic ductal 58 myeloablative 58 Transfusions 58 Interferon beta 58 Surgical resection 58 Temodar ® 58 immunosuppressive regimens 58 HuCNS SC ® 58 laparoscopic nephrectomy 58 demonstrated antitumor activity 58 pancreatic islet 58 lymphomas leukemias 58 concurrent chemoradiation 58 skeletal myoblasts 58 ABO incompatible 57 steroid refractory 57 chemoresistant 57 Thymoglobulin ® 57 Inhaled nitric oxide 57 CellCept mycophenolate mofetil 57 Carotid endarterectomy 57 Allogeneic 57 OnDose TM 57 cadaveric organ 57 multipotent adult 57 bone grafting procedures 57 pulmonary artery banding 57 Corneal transplants 57 allogeneic HSCT 57 hESC derived cardiomyocytes 57 abnormal p# 57 metastatic neuroendocrine tumors 57 hematopoietic stem cell 57 Soluble CD# 57 beta islets 57 Bone marrow transplantation 57 PLX STROKE targeting 57 mutated K ras 57 kidney fibrosis 57 bone marrow mononuclear cells 57 Madin Darby canine 57 haematopoietic 57 GRNOPC1 contains 57 tumor angiogenesis inhibitors 57 bioengineered tissue 57 Islet cells 57 anastomotic devices 57 intermittent hemodialysis 57 HeartWare System 57 immune suppressants 56 Circulating tumor cells 56 Sipuleucel T 56 cisplatin gemcitabine 56 periodontal tissues 56 cellular immunotherapy 56 engrafted cells 56 R vitespen 56 Gleevec resistant 56 autologous transplantation 56 autologous transplant 56 clonogenic 56 cardiac allograft vasculopathy 56 limbal stem cell 56 CYT# potent vascular disrupting 56 organizations OPOs 56 pancreatic adenocarcinoma 56 stage IIIA 56 candidates Azedra TM 56 transplantation HSCT 56 noninvasive outpatient 56 CardioPass TM 56 antimitotic 56 BEXXAR Therapeutic Regimen 56 refractory Hodgkin 56 thymectomy 56 intra cytoplasmic sperm 56 cervical prostate 56 Liver transplantation 56 echocardiographic parameters 56 undifferentiated stem cells 56 HDL Selective Delipidation 56 produces radioisotopes 56 cervical lymph node 56 Platinol ® cisplatin 56 cytoreduction 56 deCODE ProstateCancer TM 56 deCODE BreastCancer 56 Canvaxin TM 56 hA# 56 pancreatic lung 56 insulin secreting beta 56 autologous SCT 56 pig islets 56 limb sparing 56 donor cornea 56 porcine islets 56 BrachySil TM 56 AGTR1 56 Hematopoietic 56 islet isolation 56 Diabetic Foot Ulcer 56 Progenitor cells 56 colorectal metastases 56 regenerative therapy 56 transplanted embryonic 56 inhibit platelet function 56 hematopoietic blood 56 ADVEXIN therapy 56 calcineurin inhibitor 55 humanised monoclonal antibody 55 hepatorenal syndrome 55 oral clodronate 55 intensity allogeneic stem 55 Zenapax 55 leukemia multiple myeloma 55 CTAP# Capsules 55 containing abacavir 55 CD8 + cytotoxic 55 autologous peripheral 55 hematopoietic stem 55 gastrointestinal stromal tumors GISTs 55 humanized therapeutic 55 prostatic tissue 55 hematologic malignancy 55 Coronary stents 55 dilated cardiomyopathy DCM 55 stem cell transplantations 55 Fibroblast 55 hESC derived 55 PI3K/Akt pathway inhibitor 55 Monoclonal antibody 55 biotherapy 55 Ataluren 55 Coronary artery bypass 55 Balloon angioplasty 55 leukemia lymphoma multiple myeloma 55 pancreatic tissue 55 Certican 55 inflammatory dermatoses 55 HepaMate 55 Amgen Neulasta ® 55 pain palliation 55 immunotherapeutic approaches 55 PYY nasal spray 55 Skin grafting 55 retroviral vectors 55 Shark cartilage 55 Prognostic factors 55 StemEx R 55 specialist Richard LaPensee 55 mesenchymal stem cells MSCs 55 intimal hyperplasia 55 AFRS TM 55 LHRH receptor positive 55 carotid artery blockage 55 accumulate preferentially 55 uro oncology 55 Francis Delmonico 55 CO2 TMR 55 Bayer HealthCare Onyx Pharmaceuticals 55 Granulocyte Colony Stimulating Factor 55 non myeloablative 55 hypocalcaemia 55 Dr. Borlongan 55 Ribavirin causes 55 lymphoproliferative disease 55 Balloon sinuplasty 55 renal allograft 55 liver grafts 55 bone marrow stromal cells 55 perianal fistulas 55 either acutely decompensated 55 deCODE AF TM 55 novel immunotherapies 54 therapeutic regimens 54 chemo resistant 54 rituximab Rituxan 54 haematopoietic stem cells 54 cadaveric donors 54 anti angiogenic agents 54 mesangial 54 arterial grafts 54 malignant ascites 54 urologic diseases 54 immunosuppressive medications 54 ® bortezomib 54 reconstructive urological general 54 Mesenchymal 54 Phage Pharmaceuticals 54 continuous ambulatory peritoneal 54 preemptive analgesia 54 lymphoid tumors 54 Accelerated Partial Breast Irradiation 54 5q deletion 54 intra arterial chemotherapy 54 dyskeratosis congenita 54 tumor metastases 54 Evoltra ® 54 basiliximab 54 Neo Bladder Augment 54 interferon alpha IFN alpha 54 thoracoscopic lobectomy 54 microcirculatory improvement 54 radiochemotherapy 54 periodontal defects 54 parathyroid carcinoma 54 pharmacogenomic translational research 54 metastatic pancreatic 54 Lymph node 54 Bone marrow transplant 54 lung liver pancreas 54 antiangiogenic agent 54 thymosin beta 4 54 cells hESCs 54 implantable centrifugal rotary 54 Kidney transplantation 54 KRAS mutant 54 R sorafenib tablets 54 allogeneic HCT 54 previously untreated follicular 54 PresbyLens ® 54 substantially excreted 54 Artificial pancreas 54 curative therapy 54 retransplantation 54 pharmacologic approaches 54 Polycystic 54 Tasigna prolongs 54 G#DT 54 neuro stimulation 54 novel emulsion formulation 54 descending thoracic 54 myelomas 54 transplanted islets 54 immunosuppressive therapies 54 Gregg Allman undergoes 54 thrombocytopenic 54 Mitomycin C 54 hypervascular tumors 54 Delayed Graft Function 54 novel therapeutic antibodies 54 plus dacarbazine 54 hematopoietic cells 54 bioartificial 54 Cx# [002] 54 Achieves Primary Endpoint 54 Alessandro Riva 54 endocrinology gastroenterology 54 umbilical stem cell 54 adipose stem cells 54 Virulizin ® 54 hES cells 54 Bioartificial 54 gamma globin gene 54 FUSILEV enhances 54 refractory angina 54 Novartis Afinitor 54 multipotent stem cells 54 Vidaza ® 54 immunologic diseases 54 Donated organs 54 donor liver transplantation 54 regenerative tissue 54 Radical prostatectomy 54 YONDELIS 54 antiangiogenic therapy 54 Mitral valve repair 54 biodegradable biocompatible 54 HuMax TAC 54 adipose derived regenerative 54 chronic granulomatous disease 54 Campath alemtuzumab 54 retinal ischemia 54 gemifloxacin mesylate tablets fluoroquinolone 54 ImmuKnow 54 percutaneous transluminal 54 ® lenalidomide 54 Immunosuppressive drugs 54 gp# vaccine 54 gynecologic procedures 54 refractory metastatic 54 polycythemia vera essential thrombocythemia 54 chronic leukemias 54 hip osteonecrosis avascular 54 mononuclear cell 54 induce remission 54 Lymphoid 54 commercialize deforolimus 54 allogeneic transplants 54 placental cells 54 Squamous cell 54 antiangiogenic agents 54 NSAID induced GI 54 autologous cellular therapy 54 mesenchymal stem cell 54 cervical lymph nodes 53 Immunosuppressive 53 Extracting stem cells 53 5 fluorouracil leucovorin 53 mTOR inhibition 53 hepatic metastases 53 Cerashield TM 53 intra abdominal abscess 53 adipose tissue derived 53 haematologic 53 taxane refractory 53 metabolomic profiles 53 circulating endothelial cells 53 stage IIIb IV 53 HIPEC 53 surgically resectable 53 K ras mutations 53 MediGene focuses 53 neovasculature 53 granulocyte 53 Embryonic stem cells ESCs 53 myocardial function 53 metastatic bladder 53 urethral stricture 53 Simulect 53 Prolastin A1PI 53 multiorgan 53 mutated KRAS 53 multiple myeloma MM 53 Anticalins R 53 rituximab refractory 53 Myoblast Program 53 transplanters 53 Ph + acute lymphoblastic 53 castrate resistant 53 evaluating CK # 53 Grafts 53 Tectin TM 53 ReN# 53 adipose derived stem cells 53 Temsirolimus 53 transvenous 53 Oocyte 53 progenitor cells derived 53 metastatic malignant 53 collagen vascular 53 bone marrow transplantations 53 hMG 53 AV grafts 53 visit www.rtanswers.org 53 Kurella Tamura 53 retinal pigment epithelial cells 53 EGFR mutation positive 53 chemopreventive agents 53 neovascularisation 53 MitraClip device 53 antiplatelet therapies 53 autologous stem cell 53 subconjunctival injection 53 donor pancreases 53 potent inducer 53 thalidomide Thalomid 53 GORE TAG Device 53 abnormal hematopoietic cells 53 kidney allograft 53 nilotinib Tasigna ® 53 removed laparoscopically 53 CardioWest TAH t 53 TransVax ™ 53 name Cetrotide R 53 selective agonists 53 Amgen Neulasta R 53 Hepatocytes 53 cell transplantation 53 locoregional disease 53 aortic root replacement 53 AAV vectors 53 synthase TS 53 infantile NCL 53 patients receiving myelosuppressive 53 engineered bladders 53 balloon valvuloplasty 53 Benign tumors 53 Hematopoietic stem cells 53 human leukocyte antigens 53 Neoral 53 regenerating tissues 53 Uterine fibroid embolization 53 M# rationally 53 Acquired Cardiovascular Disease 53 placental stem cells 53 receiving XGEVA 53 biliary tract cancer 53 prevent hemolytic 53 T1c 53 fibrin deposition 53 diseased kidneys 53 recovery CRp 53 peptibody 53 non resectable liver 53 pluripotent embryonic 53 oncologic outcomes 53 GRNCM1 53 ATRA IV 53 Combivir Kivexa 53 psoriasis rheumatoid arthritis 53 5 HT2A serotonin 53 allograft tissue 53 renal tumors 53 Generx TM 53 Older corneas 53 bone allografts 53 Cerashield ™ 53 pancreatic endocrine 53 refractory acute myeloid 53 HIV HCV coinfected 53 LymphoStat B belimumab 53 hepatic arterial 53 lung esophageal 53 Papillary 53 transplantation 53 Liver transplants 53 thoracic aortic aneurysms 53 commercialize technological innovations 53 gastroenterology obstetrics gynecology 53 external beam radiotherapy 53 small molecule activators 53 HepaMate ™ 53 immunosuppressant medication 53 pamidronate 53 antiproliferative effects 53 adult mesenchymal stem 53 Antitumor Activity 53 cytotoxicity assays 53 leukemias lymphomas 53 non mutated KRAS 53 diagnose coronary artery 53 VEGF induced 53 neoplastic cells 53 targeted antifolate 53 MyoCell TM 53 arteriovenous fistula 53 acinar 53 sCD# 53 contractile muscle 53 antitumor effect 53 pro angiogenic 53 immune suppressing medication 53 percutaneous biopsy 53 allogeneic SCT 53 dermal collagen 53 GIST tumors 53 MYDICAR ® 53 mild vasodilator 53 prostate carcinoma 53 myopathies 53 autologous bone marrow 53 surgical aortic valve 53 vero cells 53 hematological disorders 53 tested eribulin 53 Atypical Hemolytic Uremic Syndrome 53 drug ISA# 53 Methotrexate MTX 53 transfusion syndrome 53 vascularisation 53 exocrine glands 52 nonischemic 52 HIF 1α 52 carcinoma HCC 52 metastatic GIST 52 BHT DNA 52 thalassemia sickle cell 52 renal transplants 52 HLA matched 52 rFactor XIII 52 Kidney transplants 52 Activase 52 Azacitidine 52 Belldegrun 52 Hyperparathyroidism 52 included exfoliative dermatitis 52 autologous fat 52 juvenile chondrocytes 52 cystic fibrosis chronic pancreatitis 52 urothelial cancer 52 immunosuppressant medications 52 Vascugel 52 function DGF 52 castration resistant hormone refractory 52 tumor immunology 52 neurovascular diseases 52 Bucindolol 52 hormonally sensitive 52 tendon dislocated shoulder 52 Bayer Nexavar 52 replacements cataract surgery 52 VIBEX MTX 52 CMV infections 52 mitoxantrone plus 52 immunosuppressive medication 52 haematopoietic cells 52 Allovectin 7 ® 52 hypereosinophilic syndrome 52 INTEGRILIN R eptifibatide Injection 52 hematological diseases 52 ECD kidneys 52 cisplatin resistant 52 embryonic stem cells ESCs 52 recurrent glioblastoma 52 venous stasis ulcers 52 underwent liver transplantation 52 nephron sparing 52 bone morrow 52 Pyridorin 52 Sentinel Lymph Node Biopsy 52 liposomal formulation 52 glial tumors 52 mononuclear 52 skeletal metastases 52 Liposomal Grb 2 52 aortic tissue 52 diseased tissues 52 adjuvant systemic 52 autografts 52 moderate immunologic 52 microcirculatory improvement helping 52 HepDirect prodrug 52 nonpharmacologic 52 neurology immunology 52 NeoLipid R 52 endoscopic vein 52 SIADH 52 Accelerating apoptosis may 52 recurrent glioblastoma multiforme 52 arterio venous 52 Factor XIII 52 hematopoietic cancers 52 prospectively stratified 52 TÎ ² 4 52 adrenocortical cancer 52 endoluminal 52 urethral strictures 52 chemosensitivity 52 dasatinib Sprycel 52 proximal tubules 52 Platelet Rich Plasma PRP 52 percutaneous cryoablation 52 neurons degenerate 52 Darinaparsin 52 Basal cell 52 leukaemic cells 52 Adipose Derived Stem Cells 52 allogeneic transplant 52 bevacizumab Avastin ® 52 Synchrony lens 52 localized renal 52 IMiDs 52 convulsive disorders 52 evaluating picoplatin 52 bladder ovarian 52 Allograft 52 ER CHOP 52 lymphoid malignancies 52 Umbilical cord 52 acadesine 52 Tß4 52 gastric carcinomas 52 refractory chronic lymphocytic 52 humanised antibody designed 52 rat hepatocytes 52 Peptic ulcer 52 beta islet cells 52 Adjuvant chemotherapy 52 microtubule inhibitor 52 genetics immunology 52 infectious diseases autoimmune diseases 52 unresectable liver cancer 52 Imatinib mesylate 52 PEGylated interferon 52 Plasmin 52 leukapheresis 52 Leukemia lymphoma 52 antibody mediated 52 liver metastasis 52 acetonide FA 52 tumor subtype 52 Coronary artery bypass graft 52 monoclonal antibody therapies 52 Cancidas 52 Embolization 52 GVAX ® 52 induced tumor regression 52 GI GVHD common 52 metastatic renal 52 therapeutically useful 52 mTOR mammalian target 52 combining voreloxin 52 fine needle aspirate 52 Sirtex SIR Spheres microspheres 52 metastatic colorectal 52 epoetin alpha 52 efaproxiral 52 idiotype vaccines 52 AV fistulas 52 targeted nucleotide prodrug 52 Gleevec Glivec 52 Exelixis compounds 52 non porcine pancreatic 52 posttransplant 52 AAG geldanamycin analog 52 novel VDA molecule 52 vitro maturation IVM 52 graft dysfunction 52 Uncontrolled hypertension 52 livers kidneys 52 Multipotent 52 IMiDs ® compound 52 Pre implantation genetic 52 adipose stem 52 mutated p# 52 busulfan 52 prognostic indicators 52 hMSCs 52 posttranslational modification 52 pharmacologic intervention 52 pancreatic islet cells 52 colorectal adenocarcinoma 52 desmopressin acetate 52 secondary amenorrhea 52 CMV vaccine 52 synthetic grafts 52 ATIR 52 stent grafting 52 rhFVIIa 52 histologies 52 ATPace TM 52 transplanted livers 52 myocardial infarction ventricular fibrillation 52 Metastatic colorectal cancer 52 Letairis ambrisentan 52 docetaxel Taxotere ® 52 immune globulins 52 osteochondral allograft 52 CentriMag 52 benign prostatic hyperplasia enlarged 52 bioprosthetic 52 Chronic lymphocytic leukemia CLL 52 malignant pheochromocytoma 52 renal cell carcinomas 52 immunologically matched 52 Drug Prevents 52 immunological rejection 52 fibrate drugs 52 Coronary Artery Bypass Graft 52 Elafin 52 haematological cancers 52 evaluate ZFP Therapeutic 52 oncology dermatology 52 Minimally invasive surgery 52 hormonally responsive 52 bone marrow stem cell 52 MENOPUR 52 photodynamic treatment 52 fibrosarcoma 52 Cryosurgery 52 Mesenchymal stem cells 52 adeno associated viruses 52 crossmatch 52 denileukin diftitox 52 antithymocyte globulin 52 branching morphogenesis 52 cell culturing genome 52 DNA methylation patterns 52 OPCAB 52 Aeolus Pharmaceuticals Announces 52 adenovirus mediated 52 breast ovary 52 Adult Stem Cell Therapy 52 nonsquamous 52 Aortic valve 52 pancreatic transplants 51 lactate dehydrogenase LDH 51 Bioengineered 51 survivin expression 51 Hoerstrup 51 leucocytes 51 BCR ABL protein 51 electrophysiological properties 51 pancreatic transplantation 51 Carotid artery stenting 51 treat musculoskeletal metabolic 51 peritoneal carcinomatosis 51 hyaluronidase enzyme 51 Stage IIB 51 JAK#/JAK# inhibitor CYT# 51 pancreatic islet beta 51 non squamous histology 51 autologous transplants 51 myelodysplastic myeloproliferative diseases 51 homograft 51 Human cl 51 bone marrow derived mesenchymal 51 receptor tyrosine kinase inhibitor 51 tuberous sclerosis TS 51 transarterial chemoembolization 51 Preimplantation genetic diagnosis 51 lymphoid cells 51 Stinging nettle 51 Nepal Aryal 51 Crofelemer budesonide foam 51 extrapleural pneumonectomy 51 periodontal gum 51 E2F Decoy 51 RhuDex R 51 successfully commercialize Iluvien 51 spontaneously regress 51 Autologous 51 biologic therapeutics 51 ascending aortic 51 Nanobody R 51 AIDS prophylaxis congestive 51 fibrotic disease 51 syngeneic 51 encapsulated porcine insulin 51 cyclophosphamide chemotherapy 51 reimplantation 51 TNF alpha antagonist 51 hematopoietic stem cells HSCs 51 Fingolimod 51 Adrenergic 51 Stereotactic Body Radiation Therapy 51 pluripotent human 51 cosmetically acceptable 51 tissue homeostasis 51 non splenectomized 51 nephron sparing surgery 51 Callisto initiated 51 TRAIL induced apoptosis 51 Induced pluripotent stem cells 51 BRCA deficient 51 percutaneous vertebroplasty 51 essential thrombocythemia ET 51 chronically immunosuppressed solid 51 esophageal gastric 51 relapsed leukemia 51 regenerate diseased 51 contractile function 51 TO AVOID PREGNANCY WHILE 51 LifeCradle ® 51 RRM1 51 oncological outcomes 51 locoregional recurrence 51 maximally tolerated 51 oncology virology 51 histologic subtypes 51 Bioaccelerate compounds under 51 Nilotinib 51 Glioblastoma Multiforme GBM 51 bronchopulmonary dysplasia BPD 51 liposomal doxorubicin 51 keratoplasty 51 Carcinoid tumors 51 Triapine R 51 surgical debulking 51 CYP#A# CYP#D# 51 Endometrial 51 Autogenous 51 products BioTime develops 51 cardiac myocytes 51 CMV seropositive 51 bFGF 51 Novavax VLP vaccine 51 radiosensitive 51 adipose derived stem cell 51 ATIR ™ 51 damaged cirrhotic liver 51 XL# anticancer compounds 51 multivessel coronary artery 51 viral inactivation 51 tumor xenograft models 51 underwent resection 51 pancreatic prostate 51 HLA markers 51 R Saizen R 51 neural regeneration 51 subcutaneous immunoglobulin 51 angiogenic therapy 51 insulin secreting 51 pacemaker implantation 51 evaluating Prochymal 51 Capsule endoscopy 51 lymphangiogenesis 51 MyVax ® 51 valve implantation 51 basal cell carcinoma squamous 51 effector function 51 hormone receptor status 51 develop HBV reactivation 51 cryotherapy freezing 51 intra abdominal infections 51 renal transplantation 51 thromboxane A2 51 Mitroflow 51 thyroid parathyroid 51 Minimally Invasive Procedure 51 periodontal tissue 51 Cumulase 51 Salix Pharmaceuticals Announces 51 TroVax ® 51 IgG preparations 51 de novo lesions 51 smoldering myeloma 51 ischemia reperfusion 51 radiosensitivity 51 Chronic myeloid leukemia CML 51 smoldering multiple myeloma 51 femoral popliteal 51 Li Fraumeni Syndrome 51 coagulation disorders 51 laparoscopic colon 51 hematopoietic progenitor cells 51 BRAF mutant 51 Bone grafts 51 sunitinib Sutent 51 manufactures minimally invasive 51 underwent balloon angioplasty 51 standard immunosuppressive therapies 51 hepatectomy 51 ImmuKnow R 51 TRIOLEX HE# APOPTONE HE# 51 number NCT# ClinicalTrials.gov 51 oral squamous cell 51 Photodynamic therapy PDT 51 HIV coinfected 51 HEK# 51 limbal stem cells 51 proliferative disorders 51 modified RECIST criteria 51 therapeutic apheresis 51 PrevOnco ™ 51 myocardial revascularization 51 autologous adult 51 regenerative medicine therapies 51 bone morphogenetic proteins 51 Arteriovenous 51 Multi Lineage Progenitor 51 Romiplostim 51 antiplatelet drugs 51 cryptogenic cirrhosis 51 multitargeted 51 Panzem NCD 51 Cytarabine 51 STEEN Solution ™ 51 localized prostate 51 papillary renal cell carcinoma 51 sapacitabine CYC# 51 transplanting insulin 51 autologous tissue 51 intravesical infusion therapy 51 lung fibrosis 51 Adult Stem Cells 51 indolent follicular non 51 Peripheral Blood 51 GATA3 51 Anticalins ® 51 inhibiting enzymes 51 factor G CSF 51 squamous cell lung cancer 51 ERK1 2 51 clot busting therapy 51 porcine derived 51 functional mitral regurgitation 51 tissue allografts 51 Autoantibodies 51 metabonomics 51 induced anemia 51 relapsed ALL 51 cystic fibrosis transmembrane 51 REMINDER ORLive Presents 51 AdhTAP 51 polysaccharide polymer 51 beta globin gene 51 malignant tissue 51 Cell Transplants 51 poloxamer 51 Placental 51 diseased corneas 51 Antigen Specific 51 mediated inhibition 51 cranial irradiation 51 Angiox ® 51 platform HDL Mimetic 51 recurrent metastatic 51 immunosuppressants 51 RQ PCR 51 Trastuzumab DM1 51 lung epithelium 51 glutamic acid decarboxylase 51 mda 7 51 prasterone 51 TGF alpha 51 adipose derived 51 Vaxfectin TM 51 kidney transplant recipients 51 liver transplant recipients 51 platelet inhibitor 51 HEPLISAV TM hepatitis B 51 CYP#A# substrate 51 myeloid metaplasia 51 cells cardiomyocytes 51 Mitral valve 51 galiximab 51 muscular dystrophy cystic fibrosis 51 reimplanting sperm producing 51 neutrophil infiltration 51 volociximab 51 targeted radiotherapeutic 51 catheter occlusion 51 please visit http:/www.avastin.com 51 neoplastic 51 kidney pancreas 51 metastatic gastric 51 Retrograde ejaculation 51 commercialize CorMedix drug 51 immunocompetent 51 internal thoracic artery 51 mononuclear cells 51 Albuferon albinterferon alfa 2b 51 Eosinophils 51 arterial venous 51 transplants CBTs 51 arteriovenous fistula AVF 51 CardioWest artificial heart 51 mouse testes 51 AlloMap molecular expression 51 osteogenic 51 Minimally invasive procedures 51 upregulating 51 CardioPass 51 hemodynamically stable 51 LPLD 51 LDLT 51 biventricular 51 ACTEMRA TM 51 prostate bladder 51 adipose cells 51 ovarian breast 51 Parkinson disease multiple sclerosis 51 bone spurs bulging 50 antiangiogenic drugs 50 Pancreas Cancer 50 BRAF gene mutations 50 antibiotic regimens 50 PD2i CA Cardiac Analyzer 50 lung epithelial